| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |

From the Departments of Laboratory Medicine and Pathology and
Pediatrics,*
University of Minnesota Medical School,
Minneapolis, Minnesota; and the Servicio de Hemoterapia y
Hemostasia,
Hospital Clinic, Barcelona, Spain
| Abstract |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
Ultrastructural studies using
immunocytochemical techniques have demonstrated that GPIIb-IIIa
receptors are distributed on external and internal platelet membranes
and on the membranes of
-granules.5
Although detailed
morphometric studies are not available, it seems that GPIIb-IIIa
receptors are homogeneously distributed on external versus
internal membranes of platelets.6
The overall impression
from ultrastructural and flow cytometric studies is that the internal
pools of GPIIb-IIIa located in the OCS and
-granules could supply
additional receptors during the process of activation.7-9
The amount of GPIIb-IIIa stored in internal pools could account for
about 100% of the surface levels.10
Immunocytochemical techniques have also demonstrated that the GPIb
complexes are distributed on external and internal platelet
membranes,11,12
membranes of
-granules,13
and dense bodies.14
Differences in opinion exist in the
literature regarding the quantitative distribution of GPIb on external
and internal membranes in resting platelets. Some authors have found
that the density of labeling for GPIb within the OCS is less than that
observed on the platelet surface.15,16
Other workers have
failed to note significant differences,12,17
whereas some
using enzyme-linked immunsorbent assay techniques with monoclonal
antibodies have predicted a large internal pool of GPIb that could
replenish any amount of GPIb lost from the external
membrane.18
The latter authors estimated the number of
internal copies of GPIb was 3 to 4 times greater than the number of
GPIb molecules present on the platelet surface, figures relatively
higher than those estimated for GPIIb-IIIa.
Immunocytochemical techniques have inherent limitations to access antigens located in external or internal membranes.19,20 The difficulty for monoclonal antibodies to gain access to GPIIb-IIIa located on internal membranes of the platelet OCS has been known for a long time.21 Better access to these antigens can be gained when Fab fragments of the antibodies or smaller probes are used.10,21
In the present study, we have explored the distribution of GPIb on external and internal membranes of platelets in their resting state. Several approaches were used to facilitate the accessibility of antibodies to antigens located in very narrow portions of the OCS. Ultrathin cryosections of platelets from patients with giant platelet disorders, including the May-Hegglin anomaly and Epsteins syndrome, were exposed to polyclonal antibodies or to mixtures of monoclonal antibodies (AP1 and 6D1). The same techniques were applied to normal platelets where OCS of normal platelets was artificially dilated by exposure to cytochalasin-B or to hypertonic buffers. Differences in labeling were morphometrically quantified.
| Materials and Methods |
|---|
|
|
|---|
Polyclonal antibodies to glycocalicin or a mixture of monoclonal antibodies specific for GPIb (AP1 and 6D1) were used for immunolabeling. The polyclonal antibody against GPIb, generously provided by Dr. Kenneth Clemetson (Bern, Switzerland), recognizes the glycocalicin portion of the glycoprotein and inhibits ristocetin-induced agglutination of platelets.22 Monoclonal antibodies AP1 and AP2, kindly provided by Dr. T. J. Kunicki (La Jolla, CA) and 6D1, kindly provided by Dr. Barry Coller, Mount Sinai Medical Center (New York, NY), have been characterized and used in previous studies.12,22,23
Preparation of Platelets
Blood for the present study was obtained after informed consent from normal donors and from previously characterized patients with diagnosed bleeding and giant platelet disorders. None of the individuals studied had taken aspirin for at least 10 days. Following venipuncture, the samples were mixed immediately with citrate-citric acid-dextrose (CCD), pH 6.5 (93.0 mmol/L sodium citrate, 7.0 mmol/L citric acid, 140 mmol/L dextrose), in a ratio of 9 parts blood to 1 part anticoagulant. Platelets from platelet-rich plasma (PRP) were separated by centrifugation at room temperature for 20 minutes at 100 x g. Platelets were washed twice with equal volumes of CCD containing 5 mmol/L adenosine and 3 mmol/L theophylline,24 centrifuged to pellets at 900 x g for 15 minutes, and suspended in Hanks balanced salt solution (HBSS).
Depending on experimental purposes HBSS prepared from a x10 concentration was diluted to normal (x1) or x2 strength. For other experiments platelets in cytochalasin B (10-5 M final concentration) was added to HBSS. Platelets were always incubated in the corresponding HBSS media for 1 hour at 37°C before fixation in 4% paraformaldehyde in PBS, pH 7.2.
Preparation and Immunolabeling of Cryosections from Platelets Suspensions
Aliquots of washed platelets fixed in 4% paraformaldehyde were concentrated to a pellet by centrifugation. The supernatant was removed, fresh fixative added, and fixation of the pellet continued for 24 hours at 4°C. After this period, small portions of the pellets were washed and further infiltrated for 2 hours in a mixture of polyvinylpyrrolidone and sucrose as recommended by Tokuyasu.25 Pyramid-shaped blocks of the infiltrated pellets were cut, mounted on metal stubs, and frozen in liquid nitrogen. Cryosections were obtained from these blocks according to ultracryomicrotomy techniques described elsewhere.26 Sections were cut at -90°C with a MT6000-XL ultracryotome provided with a CR2000 cryounit (RMC, Tucson, AZ) and stored on formvar-coated copper grids.
An indirect immunocytochemical technique was used for the localization of GPIb. Sections were first incubated in 1:100 dilution of the antibody to GPIb for 45 minutes. After repeated washing with PBS, the location of the primary antibody was visualized by incubation with protein A-colloidal gold or goat anti-mouse IgG-colloidal gold (Amersham International, Poole, UK). The excess of gold particles was removed by washing in PBS. Finally, labeled grids were stained and embedded in a mixture of 2% polyvinyl-alcohol (PVA) and 0.3% uranyl acetate27 before examination in a Philips 301 electron microscope.
Morphometric Quantification
The distribution of colloidal gold particles on the surface of immunolabeled platelets was analyzed in en face electron micrographs printed at final magnifications around x60,000. The morphometric analysis was performed only on platelets with clearly distinguishable OCS. At least 10 photomicrographs were analyzed from each of the two patients with giant platelet disorders, normal platelets exposed to hypertonic conditions and cells incubated with cytochalasin B. The density of labeling on external and internal membranes was determined and expressed per micron.28 A ratio of internal versus external density was calculated for each platelet micrograph analyzed. First, the number of gold particles related to internal membranes was determined on cross-sectioned membranes of the OCS and the total perimeter screened was recorded (usually 46 microns). Clusters of 2 or more particles were always considered as one event. Immediately after, an equivalent perimeter was randomly screened on the external surface of the same platelet. Ratios close to 1 indicate that the labeling was equally distributed on external and internal membranes. Ratios below 1 indicate a more frequent distribution of receptors on external membranes.
Statistics
Average values and standard deviations derived from morphometric data were calculated. Students t-test was used for statistical comparisons.
| Results |
|---|
|
|
|---|
Normal Resting Platelets
The distribution of GPIb/IX receptors on external and internal membranes of resting platelets has been described in previous reports from our laboratory. The work has shown that immunogold particles detecting GPIb/IX are randomly dispersed on exposed surfaces of discoid platelets and membranes lining channels of the OCS. However, narrow segments of the OCS channels were often less well labeled with immunogold particles than more dilated elements. Rates of labeling on internal versus external membranes in normal resting platelets averaged 0.76 ± 0.14 (mean ± SD). The variability may account in part for differences in opinion regarding the frequency of GPIb/IX on external membrane of resting cells. Therefore, the experiments described below were carried out to resolve the problem.
Giant Resting Platelets
Platelets from patients with the May-Hegglin anomaly and
Epsteins syndrome contain extensive amounts of dilated internal
membrane frequently associated with elements of the dense tubular
system (DTS) in membrane complexes (Figures 1 and 2)
.
Frozen thin sections of giant platelets incubated with AP1 and 6D1 to
detect GPIb/IX and post stained with anti-mouse Ig G coupled to 5 nm
gold reveal generous labeling of internal and external membranes
(Figures 3 and 4)
. No difference in the frequency of
GPIb on the outer and inner membranes could be detected with rates of
labeling internal versus external averaging 0.93 ±
0.17.
|
|
|
|
Cytochalasin-B (CB) inhibits assembly of new actin filaments in
stimulated platelets. It also has been reported to block clearance of
GPIb/IX receptors from exposed surfaces to interior membranes of
activated platelets and causes dilatation of the OCS in resting
cells.11,29
Frozen thin sections of platelets incubated
with 10-5 M CB revealed preservation of discoid
form despite dilatation of channels making up the OCS. Staining
CB-treated cells for GPIb/IX revealed immunogold particles randomly
dispersed on exposed surfaces and membranes lining channels of the OCS
(Figures 57)
.
Analysis of particle frequencies on the internal and external membrane
revealed no significant differences (1.01 ± 0.31).
|
|
|
Exposure of resting platelets to a twice concentrated salt
solution causes dehydration of the matrix and dilatation of OCS
channels.30
Frozen thin sections of platelets exposed to
hypertonic stress stained for GPIb/IX revealed uniform deposition of
immunogold particles detecting the receptor on internal and external
surfaces (Figures 810)
.
No significant differences in frequency were observed (0.96 ±
0.20).
|
|
|
Figure 11
summarizes morphometric
data obtained under the different conditions of our studies.
Morphometric analysis of labeling on membranes of control platelets
revealed a statistically significant reduction in the density of
labeling of internal membranes (P < 0.05
versus external membranes).
|
| Discussion |
|---|
|
|
|---|
The mechanism responsible for formation of giant platelets is unknown.34 As a result the membranes of the OCS may be abnormal, and it seemed reasonable to try to dilate channels of the OCS in normal platelets under conditions that should not cause translocation of GPIb/IX. CB, an agent that inhibits assembly of cytoplasmic actin filaments, was found in previous studies to make platelets more deformable to aspiration into micropipettes35 and to prevent cold-induced shape change.36 Examination in the electron microscope revealed that chilled, CB-treated platelets retained a relatively discoidal appearance, even though circumferential coils of microtubules had disappeared. The cells, however, were somewhat irregular due to dilation of OCS channels.
CB-treated platelets with a dilated OCS appeared to be an excellent model for our studies, particularly because other workers had proposed that CB prevented movement of GPIb on platelets and translocation from the exposed surface to interior membranes.11,29 The present study has shown that CB-treated platelets are excellent subjects for studying the distribution of GPIb receptors. The density of immunogold particles detecting GPIb on internal and external membranes of CB-treated platelets was not significantly different.
Exposure of normal platelets to hypertonic salt solutions causes dehydration of the cell matrix, resulting in dilatation of the OCS.30,37 The observation suggested that normal platelets prepared under hypertonic conditions might be useful for determining the distribution of GPIb on internal and external membranes. Results of the present study confirm that dilatation of the OCS occurs under hypertonic conditions, and that GPIb is homogeneously distributed on internal and external membranes of platelets exposed to these conditions.
The network of interconnecting surface membrane invaginations that make up the platelet OCS is unique. It is not found in any other type of blood cell. Sequestration of the tortuous, tube-like channels making up the OCS within the cytoplasm of resting platelets has made it difficult to appreciate that it is surface membrane, not some specialized compartment originating from another membrane system in the megakaryocyte precursor. Behnkes38 early studies and subsequent investigations39 have shown that channels of the OCS are continuous with the exposed surface of the platelet and develop by invagination of the megakaryocyte membrane during sequestration of its cytoplasm into subunits.
However, internalization of surface membrane in the form of narrow channels does make it difficult to access or isolate them for definitive biochemical studies. As a result, some investigators consider the OCS as a membrane entity different from the exposed cell surface, even though their work supports the concept that exposed and internal membranes are continuous.11,18 This opinion has resulted in different interpretations of the distribution of receptors on exposed versus internal membranes of resting platelets and their fate after platelet activation in suspension.
Several immunocytochemical studies indicate that, in resting platelets,
GPIb is found at a higher frequency on external membranes than on the
membranes lining the OCS.14,15,40,41
Nevertheless, other
methodological approaches have predicted a larger concentration of GPIb
located in internal pools than is available on the exposed
surface.18
In contrast, preliminary studies with
polyclonal antibodies suggested that GPIIb-IIIa was observed on the
plasma membrane, the OCS, and the
-granule membrane6
without emphasizing possible differences in density. Yet when
micrographs of published work on immunocytochemical labeling of
GPIIb-IIIa in cryosections are studied critically,14,41
the impression gained is that GPIIb-IIIa has a distribution similar to
that claimed for GPIb, with more intense labeling on the surface
membrane and weaker or no labeling on many elements of the OCS.
Data from the present work suggest that receptors located on narrow channels of the OCS in resting platelets are often less efficiently labeled than those present on external membranes. In our study, a decreased labeling for GPIb was also frequently observed at points where membranes of two platelets or a platelet and a red blood cell were juxtaposed. The observation is in agreement with that reported in a previous publication detecting GPIb on resting and activated platelets.12
Problems in labeling of this type can also be found in published material from other authors who have used a similar technical approach.16 It is intriguing that the density of labeling at intersections between membranes of two colliding platelets is inferior to that seen on noncolliding membranes, where one would expect it to be doubled. It is also remarkable that an immunocytochemical approach, which fails to proportionally label membranes of juxtaposed platelets, could be used with confidence to quantify receptors located in narrow portions of the OCS. The increased labeling observed for GPIb in dilated OCS channels suggests that access of probes to this antigen is improved when the OCS is clinically or experimentally dilated.
The limitations of immunocytochemical probes to reach their targets have a variety of origins. Antibodies to receptors have limited access to internal portions of the OCS when used on platelets in suspension.10,21 The size of the probes and the absence of a flow gradient between the external and internal membranes may explain these limitations. In the case of cryosections, the efficiency of labeling is also limited, not only by the accessibility of the antigens but also by the size of the primary antibody and the secondary probe. Usually, the primary marker is a single mouse IgG (monoclonal antibody) or a mixture of rabbit IgG (polyclonal). The size of the immunoglobulin is usually around 150 kd. The marker for this primary antibody can either be IgG from another species or protein-A, generally coupled to gold.42 Protein A is a smaller molecule (40 kd), which facilitates its penetration into sections.19 The efficiency of labeling improves with smaller gold particles.43 It is remarkable that in the present study labeling was successfully achieved when a combination of polyclonal antibodies and protein A-gold (5 nm) was applied to the dilated OCS of resting giant platelets.
Griffiths and Hoppeler44 found large differences in the efficiency of immunogold techniques to label antigens located in the Golgi zone or endoplasmic reticulum. According to these authors, the cross-linking effect of fixatives, steric hindrance, and valency of both ligand and target molecules are additional factors that limit labeling efficiencies.45 In a recent article Wagner et al,46 using a humanized receptor specific for GPIIb-IIIa, found that the number of antigens available to the antibody increased up to twofold. In the opinion of these authors the increased efficiency of the humanized antibody was the critical component determining the binding of antibody molecules. It is likely that all of the previous factors, together with the elevated presence of glycocalicin in the external expansions of GPIb,47 could interfere with the labeling of GPIb pools located in deeper portions of the OCS. Moreover, despite careful and repeated washing, residual plasma proteins may remain in the OCS of isolated resting platelets and become deposited during the fixation procedure, thereby masking some glycoprotein antigens. Thus, in view of the previous considerations, we suggest that antigens located in narrow membranes are naturally less accessible to probes than those located on more exposed membranes.
According to some authors, GPIb becomes internalized during platelet activation as assessed by a decrease in labeling on the platelet surface and a parallel increase in the labeling related to the OCS.11,48,49 Interestingly, the substantial modifications predicted in these studies were not observed when polyclonal antibodies were used in combination with protein A-gold (5 nm) probes for immunolabeling.12 Based on the findings of the present study, dilation of the OCS in thrombin-activated platelets would facilitate the expression of antigenic sites recognized by antibodies, giving the impression of more intense labeling.
In a recently published article by Van Zanten et al,16 the authors detected a 50% decrease in the presence of GPIb on the surface of platelets activated with specific thrombin receptor agonist, thrombin receptor activation peptide (TRAP). Interestingly, the morphometric analysis performed by the authors showed that the density of labeling on the internal membranes of the activated platelets was still slightly below that observed on external membranes of resting platelets. Clearly, the number does not exceed the frequency observed on exterior surfaces of resting platelets, as would be required if there were no differences in the frequency of GPIb on the internal and external membranes of resting cells, as our work has shown.
In summary, our data indicate that GPIb is homogeneously distributed on external and internal membranes of resting platelets, confirming that membranes of the OCS are continuous with the external surface. Our data may help to explain apparent discrepancies among studies published from different groups on the labeling of glycoproteins located on internal membranes of resting platelets.
| Footnotes |
|---|
A Letter to the Editor based in part on this investigation was recently published (Blood 1998, 92:48744877).
Accepted for publication August 2, 1999.
| References |
|---|
|
|
|---|
granules. J Clin Invest 1980, 66:102-109
This article has been cited by other articles:
![]() |
A. J. Reininger, H. F. G. Heijnen, H. Schumann, H. M. Specht, W. Schramm, and Z. M. Ruggeri Mechanism of platelet adhesion to von Willebrand factor and microparticle formation under high shear stress Blood, May 1, 2006; 107(9): 3537 - 3545. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |